Health TrialsbyHealthPanel

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Market Research of a Slow Release Protein Substitute for the Dietary Management of PKU

XPhePiccosMR is a prospective, single-arm, open label, observational study that aims to evaluate the acceptability and tolerability of XPhe Piccos, a slow-release, phenylalanine-free protein substitute in the form of tiny tablets, for use in the dietary management of phenylketonuria (PKU) in children aged three years and older.

Participants needed: 10
Trial details
Age: 3-18Biological sex: AllType: InterventionalSponsor: metaX Institut fuer Diatetik GmbHUpdated: Oct 9, 2026Locations: 1
Eligibility criteria

Diagnosis of PKU or HPA requiring a phenylalanine-free protein substitute. [+3]

Presence of serious concurrent illness. [+4]

Read more
Status: Not yet recruiting

Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies

The purpose of this prospective, observational study is to evaluate the tolerability and acceptability of Zero minis, a range of protein substitute tablets for use in the dietary management of children with either TYROSINAEMIA Type I, II, III or ALKAPTONURIA, HOMOCYSTINURIA, or MAPLE SYRUP URINE DISEASE (MSUD) over the age of 7 years.

Participants needed: 15
Trial details
Age: 7-18Biological sex: AllType: ObservationalSponsor: metaX Institut fuer Diatetik GmbHUpdated: Mar 7, 2024
Eligibility criteria

Diagnosis of Tyrosinaemia type I, II III or Alkaptonuria requiring a tyrosine- a... [+5]

Presence of serious concurrent illness [+4]

Read more